Medicines | European Medicines Agency

Medicines

For help on how to get the results you want, see our search tips.

Search results

Categories

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

Product number

Authorisation status

ATC code

Marketing authorisation date

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

Medicine type

Therapeutic area

Last updated

First published

53 results

Sort by

List item

Human medicine European public assessment report (EPAR): Zurampic

lesinurad, Hyperuricemia
Date of authorisation: 18/02/2016, , Revision: 4, Withdrawn, Last updated: 31/07/2020
List item

Human medicine European public assessment report (EPAR): Zynquista

Sotagliflozin, Diabetes Mellitus, Type 1
Date of authorisation: 26/04/2019, , Revision: 3, Withdrawn, Last updated: 16/08/2022
List item

Human medicine European public assessment report (EPAR): Zynteglo

Autologous CD34+ cell enriched population that contains haematopoietic stem cells transduced with lentiviral vector encoding the βA-T87Q-globin gene, beta-Thalassemia
Date of authorisation: 29/05/2019, , , , Revision: 5, Withdrawn, Last updated: 30/11/2022